Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
intravenous drugs
Pharma
Syros starts study to drive IV to oral switch in leukemia
Syros is racing forward with its effort to develop an oral leukemia treatment, dosing the first patient in an early-phase study.
Nick Paul Taylor
Oct 5, 2021 7:50am
Siga seeks FDA approval for intravenous smallpox therapy
May 11, 2021 7:30am
Gilead nixes Veklury COVID trial, citing evolved landscape
Apr 13, 2021 11:43am